Страна: Малайзія
мова: англійська
Джерело: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
MOMETASONE FUROATE
Glenmark Pharmaceuticals (Malaysia) Sdn. Bhd.
MOMETASONE FUROATE
60 ACTUATIONS; 120 ACTUATIONS; 140 ACTUATIONS
Glenmark Pharmaceuticals Ltd.
_CONSUMER_ _ _ _MEDICATION_ _ _ _INFORMATION_ _ _ _LEAFLET_ _ _ _(RIMUP) _ MOMATE™ NASAL SPRAY MOMETASONE FUROATE 50 MCG/ SPRAY What is in this leaflet 1. What MOMATE is used for 2. How MOMATE works 3. Before you use MOMATE 4. How to use MOMATE 5. While you are using it 6. Side Effects 7. Storage and Disposal of MOMATE 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of Revision WHAT IS MOMATE AND WHAT IS IT USED FOR? MOMATE contains mometasone furoate, one of a group of medicines called corticosteroids. Momate is used in adults, adolescents and children between the ages of 3 and 11 years to treat the symptoms of hayfever (also called seasonal allergic rhinitis) and perennial rhinitis. In adults and adolescents aged 18 and over, MOMATE is also used to treat nasal polyps. In patients aged 12 and over without signs or symptoms of severe bacterial infection, MOMATE is used to treat acute rhinosinusitis. WHAT IS HAYFEVER AND PERENNIAL RHINITIS? Hayfever, which occurs at certain times of the year, is an allergic reaction caused by breathing in pollen from trees, grasses, weeds and also moulds and fungal spores. Perennial rhinitis occurs throughout the year and symptoms can be caused by a sensitivity to a variety of things including house dust mite, animal hair (or dander), feathers and certain foods. These allergies cause a runny nose and sneezing, and make the lining of the nose swell, causing a stuffy blocked-up feeling. Momate reduces the swelling and irritation in your nose and so relieves sneezing, itching and blocked-up or runny nose. WHAT ARE NASAL POLYPS? Nasal polyps are small growths on the lining of the nose and usually affect both nostrils. Momate Nasal Spray reduces the inflammation in the nose, causing the polyps to gradually shrink, thereby relieving a blocked feeling in the nose which may affect breathing through the nose. Watering from the nose, a feeling of something running down the back of the throat and loss of taste and smell may also occur. MOMATE reduces the inf Прочитайте повний документ
SAME SIZE ARTWORK LEAFLET SIZE: 276 mm x 135 mm FOLDING SIZE: 23 mm x 135 mm 23 mm 23 mm 23 mm 23 mm 23 mm 23 mm 23 mm 23 mm 23 mm 23 mm 23 mm 23 mm 25 mm PE00000 MY PANTONE BLACK PROCESS C SUPERSEDES ARTWORK CODE: PE50767 PANTONE SHADE ICONGRAPHICS CODE: PHARMACODE: NASAL SPRAY MOMETASONE FUROATE 50 MCG/SPRAY 60/120/140 METERED DOSES _For the use only of Registered Medical Practitioner or a _ _Hospital or a Laboratory_ COMPOSITION Mometasone Furoate Monohydrate equivalent to Mometasone Furoate 0.05% w/w Each spray delivers: Mometasone Furoate monohydrate equivalent to Mometasone Furoate 50 mcg Preservative: Benzalkonium Chloride BP 0.02% w/w Excipients q.s FOR INTRANASAL ADMINISTRATION DESCRIPTION: Mometasone Furoate Aqueous Nasal Spray is a metered-dose, manual pump spray unit containing a suspension of mometasone furoate. Each metered dose pump actuation of Mometasone Furoate Aqueous Nasal Spray delivers approximately 100 mg of mometasone furoate suspension, containing mometasone furoate monohydrate equivalent to 50 micrograms mometasone furoate. ACTIONS: Mometasone furoate is a topical glucocorticosteroid with local anti - inflammatory properties at doses that are not systemically active. PRECLINICAL PHARMACOLOGY AND TOXICOLOGY: Preclinical studies demonstrate that mometasone furoate is devoid of androgenic, antiandrogenic, estrogenic or antiestrogenic activity but, like other glucocorticoids, it possesses some antiuterotrophic activity and delays vaginal opening in animal models at high oral doses of 56 mg/kg/day and 280 mg/kg/day. In cell culture, mometasone furoate was shown to be at least ten times morepotent than other steroids, including beclomethasone dipropionate (BDP), betamethasone, hydrocortisone and dexamethasone; at inhibiting thesynthesis/release of IL-1, IL-6 and TNF- α . Mometasone furoate (IC = 0.12 Nm) wasalso at least six times more potent than 50 BDP and betamethasone at inhibiting IL-5 production. Also, in mixed leucocytes from atopic patients, mometasone was a more potent leukotriene pr Прочитайте повний документ